Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
8,147
archived clinical trials in
Asthma

Study of Fluticasone Propionate MDPI Compared With Fluticasone/Salmeterol MDPI in Adolescent and Adult Patients With Persistent Asthma
A 12-Week, Double-Blind, Placebo-Controlled, Efficacy and Safety Study of Fluticasone Propionate Multidose Dry Powder Inhaler Compared With Fluticasone/Salmeterol Multidose Dry Powder Inhaler in Adolescent and Adult Patients With Persistent Asthma Symptomatic Despite Low-dose or or Mid-dose Inhaled Corticosteroid Therapy
Status: Enrolling
Updated:  1/12/2016
Teva Investigational Site 12279
mi
from
Milwaukee, WI
Study of Fluticasone Propionate MDPI Compared With Fluticasone/Salmeterol MDPI in Adolescent and Adult Patients With Persistent Asthma
A 12-Week, Double-Blind, Placebo-Controlled, Efficacy and Safety Study of Fluticasone Propionate Multidose Dry Powder Inhaler Compared With Fluticasone/Salmeterol Multidose Dry Powder Inhaler in Adolescent and Adult Patients With Persistent Asthma Symptomatic Despite Low-dose or or Mid-dose Inhaled Corticosteroid Therapy
Status: Enrolling
Updated: 1/12/2016
Teva Investigational Site 12279
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Study of Fluticasone Propionate MDPI Compared With Fluticasone/Salmeterol MDPI in Adolescent and Adult Patients With Persistent Asthma
A 12-Week, Double-Blind, Placebo-Controlled, Efficacy and Safety Study of Fluticasone Propionate Multidose Dry Powder Inhaler Compared With Fluticasone/Salmeterol Multidose Dry Powder Inhaler in Adolescent and Adult Patients With Persistent Asthma Symptomatic Despite Low-dose or or Mid-dose Inhaled Corticosteroid Therapy
Status: Enrolling
Updated:  1/12/2016
Teva Investigational Site 01
mi
from
Decatur, GA
Study of Fluticasone Propionate MDPI Compared With Fluticasone/Salmeterol MDPI in Adolescent and Adult Patients With Persistent Asthma
A 12-Week, Double-Blind, Placebo-Controlled, Efficacy and Safety Study of Fluticasone Propionate Multidose Dry Powder Inhaler Compared With Fluticasone/Salmeterol Multidose Dry Powder Inhaler in Adolescent and Adult Patients With Persistent Asthma Symptomatic Despite Low-dose or or Mid-dose Inhaled Corticosteroid Therapy
Status: Enrolling
Updated: 1/12/2016
Teva Investigational Site 01
mi
from
Decatur, GA
Click here to add this to my saved trials
Study of Fluticasone Propionate MDPI Compared With Fluticasone/Salmeterol MDPI in Adolescent and Adult Patients With Persistent Asthma
A 12-Week, Double-Blind, Placebo-Controlled, Efficacy and Safety Study of Fluticasone Propionate Multidose Dry Powder Inhaler Compared With Fluticasone/Salmeterol Multidose Dry Powder Inhaler in Adolescent and Adult Patients With Persistent Asthma Symptomatic Despite Low-dose or or Mid-dose Inhaled Corticosteroid Therapy
Status: Enrolling
Updated:  1/12/2016
Teva Investigational Site 10393
mi
from
Greenville, SC
Study of Fluticasone Propionate MDPI Compared With Fluticasone/Salmeterol MDPI in Adolescent and Adult Patients With Persistent Asthma
A 12-Week, Double-Blind, Placebo-Controlled, Efficacy and Safety Study of Fluticasone Propionate Multidose Dry Powder Inhaler Compared With Fluticasone/Salmeterol Multidose Dry Powder Inhaler in Adolescent and Adult Patients With Persistent Asthma Symptomatic Despite Low-dose or or Mid-dose Inhaled Corticosteroid Therapy
Status: Enrolling
Updated: 1/12/2016
Teva Investigational Site 10393
mi
from
Greenville, SC
Click here to add this to my saved trials
Study of Fluticasone Propionate MDPI Compared With Fluticasone/Salmeterol MDPI in Adolescent and Adult Patients With Persistent Asthma
A 12-Week, Double-Blind, Placebo-Controlled, Efficacy and Safety Study of Fluticasone Propionate Multidose Dry Powder Inhaler Compared With Fluticasone/Salmeterol Multidose Dry Powder Inhaler in Adolescent and Adult Patients With Persistent Asthma Symptomatic Despite Low-dose or or Mid-dose Inhaled Corticosteroid Therapy
Status: Enrolling
Updated:  1/12/2016
Teva Investigational Site 11065
mi
from
Toronto,
Study of Fluticasone Propionate MDPI Compared With Fluticasone/Salmeterol MDPI in Adolescent and Adult Patients With Persistent Asthma
A 12-Week, Double-Blind, Placebo-Controlled, Efficacy and Safety Study of Fluticasone Propionate Multidose Dry Powder Inhaler Compared With Fluticasone/Salmeterol Multidose Dry Powder Inhaler in Adolescent and Adult Patients With Persistent Asthma Symptomatic Despite Low-dose or or Mid-dose Inhaled Corticosteroid Therapy
Status: Enrolling
Updated: 1/12/2016
Teva Investigational Site 11065
mi
from
Toronto,
Click here to add this to my saved trials
Role of RhuMab-E25 in Reducing Exhaled Nitric Oxide (NO) in Allergic Asthma
Role of RhuMab-E25 in Reducing Exhaled NO in Allergic Asthma
Status: Enrolling
Updated:  1/12/2016
Duke Univ Med Ctr
mi
from
Durham, NC
Role of RhuMab-E25 in Reducing Exhaled Nitric Oxide (NO) in Allergic Asthma
Role of RhuMab-E25 in Reducing Exhaled NO in Allergic Asthma
Status: Enrolling
Updated: 1/12/2016
Duke Univ Med Ctr
mi
from
Durham, NC
Click here to add this to my saved trials
Asthma Education Using Child Life Services and an Asthma-based Computer Game
Innovative Asthma Education Using a Unique Blend of Child Life Services and an Asthma-based Computer Game in the Pediatric Emergency Room
Status: Enrolling
Updated:  1/13/2016
Winthrop University Hospital
mi
from
Mineola, NY
Asthma Education Using Child Life Services and an Asthma-based Computer Game
Innovative Asthma Education Using a Unique Blend of Child Life Services and an Asthma-based Computer Game in the Pediatric Emergency Room
Status: Enrolling
Updated: 1/13/2016
Winthrop University Hospital
mi
from
Mineola, NY
Click here to add this to my saved trials
The Various Effects of Gaseous Albuterol on Serum Lactate
The Various Effects of Gaseous Albuterol on Serum Lactate
Status: Enrolling
Updated:  1/13/2016
University Medical Center of Southern Nevada
mi
from
Las Vegas, NV
The Various Effects of Gaseous Albuterol on Serum Lactate
The Various Effects of Gaseous Albuterol on Serum Lactate
Status: Enrolling
Updated: 1/13/2016
University Medical Center of Southern Nevada
mi
from
Las Vegas, NV
Click here to add this to my saved trials
Dose Ranging Pharmacokinetics and Pharmacodynamics Study With Mepolizumab in Asthma Patients With Elevated Eosinophils
A Multicenter, Open-label, Dose Ranging Study to Determine the Pharmacokinetics and Pharmacodynamics of Mepolizumab Administered Intravenously or Subcutaneously to Adult Asthmatic Subjects With Elevated Blood Eosinophil Levels
Status: Enrolling
Updated:  1/14/2016
GSK Investigational Site
mi
from
Winston-Salem, NC
Dose Ranging Pharmacokinetics and Pharmacodynamics Study With Mepolizumab in Asthma Patients With Elevated Eosinophils
A Multicenter, Open-label, Dose Ranging Study to Determine the Pharmacokinetics and Pharmacodynamics of Mepolizumab Administered Intravenously or Subcutaneously to Adult Asthmatic Subjects With Elevated Blood Eosinophil Levels
Status: Enrolling
Updated: 1/14/2016
GSK Investigational Site
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
Dose Ranging Pharmacokinetics and Pharmacodynamics Study With Mepolizumab in Asthma Patients With Elevated Eosinophils
A Multicenter, Open-label, Dose Ranging Study to Determine the Pharmacokinetics and Pharmacodynamics of Mepolizumab Administered Intravenously or Subcutaneously to Adult Asthmatic Subjects With Elevated Blood Eosinophil Levels
Status: Enrolling
Updated:  1/14/2016
GSK Investigational Site
mi
from
Pittsburgh, PA
Dose Ranging Pharmacokinetics and Pharmacodynamics Study With Mepolizumab in Asthma Patients With Elevated Eosinophils
A Multicenter, Open-label, Dose Ranging Study to Determine the Pharmacokinetics and Pharmacodynamics of Mepolizumab Administered Intravenously or Subcutaneously to Adult Asthmatic Subjects With Elevated Blood Eosinophil Levels
Status: Enrolling
Updated: 1/14/2016
GSK Investigational Site
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Dose Ranging Pharmacokinetics and Pharmacodynamics Study With Mepolizumab in Asthma Patients With Elevated Eosinophils
A Multicenter, Open-label, Dose Ranging Study to Determine the Pharmacokinetics and Pharmacodynamics of Mepolizumab Administered Intravenously or Subcutaneously to Adult Asthmatic Subjects With Elevated Blood Eosinophil Levels
Status: Enrolling
Updated:  1/14/2016
GSK Investigational Site
mi
from
Tallinn,
Dose Ranging Pharmacokinetics and Pharmacodynamics Study With Mepolizumab in Asthma Patients With Elevated Eosinophils
A Multicenter, Open-label, Dose Ranging Study to Determine the Pharmacokinetics and Pharmacodynamics of Mepolizumab Administered Intravenously or Subcutaneously to Adult Asthmatic Subjects With Elevated Blood Eosinophil Levels
Status: Enrolling
Updated: 1/14/2016
GSK Investigational Site
mi
from
Tallinn,
Click here to add this to my saved trials
A Multifaceted Prompting Intervention for Urban Children With Asthma
A Multifaceted Prompting Intervention for Urban Children With Asthma
Status: Enrolling
Updated:  1/15/2016
University of Rochester
mi
from
Rochester, NY
A Multifaceted Prompting Intervention for Urban Children With Asthma
A Multifaceted Prompting Intervention for Urban Children With Asthma
Status: Enrolling
Updated: 1/15/2016
University of Rochester
mi
from
Rochester, NY
Click here to add this to my saved trials
Preventative Omalizumab or Step-up Therapy for Severe Fall Exacerbations
Preventative Omalizumab or Step-up Therapy for Severe Fall Exacerbations (ICAC-20)
Status: Enrolling
Updated:  1/22/2016
National Jewish Health
mi
from
Denver, CO
Preventative Omalizumab or Step-up Therapy for Severe Fall Exacerbations
Preventative Omalizumab or Step-up Therapy for Severe Fall Exacerbations (ICAC-20)
Status: Enrolling
Updated: 1/22/2016
National Jewish Health
mi
from
Denver, CO
Click here to add this to my saved trials
Preventative Omalizumab or Step-up Therapy for Severe Fall Exacerbations
Preventative Omalizumab or Step-up Therapy for Severe Fall Exacerbations (ICAC-20)
Status: Enrolling
Updated:  1/22/2016
Childrens National Medical Center
mi
from
Washington,
Preventative Omalizumab or Step-up Therapy for Severe Fall Exacerbations
Preventative Omalizumab or Step-up Therapy for Severe Fall Exacerbations (ICAC-20)
Status: Enrolling
Updated: 1/22/2016
Childrens National Medical Center
mi
from
Washington,
Click here to add this to my saved trials
Preventative Omalizumab or Step-up Therapy for Severe Fall Exacerbations
Preventative Omalizumab or Step-up Therapy for Severe Fall Exacerbations (ICAC-20)
Status: Enrolling
Updated:  1/22/2016
Children's Memorial Hospital - Department of Allergy
mi
from
Chicago, IL
Preventative Omalizumab or Step-up Therapy for Severe Fall Exacerbations
Preventative Omalizumab or Step-up Therapy for Severe Fall Exacerbations (ICAC-20)
Status: Enrolling
Updated: 1/22/2016
Children's Memorial Hospital - Department of Allergy
mi
from
Chicago, IL
Click here to add this to my saved trials
Preventative Omalizumab or Step-up Therapy for Severe Fall Exacerbations
Preventative Omalizumab or Step-up Therapy for Severe Fall Exacerbations (ICAC-20)
Status: Enrolling
Updated:  1/22/2016
Boston University School of Medicine
mi
from
Boston, MA
Preventative Omalizumab or Step-up Therapy for Severe Fall Exacerbations
Preventative Omalizumab or Step-up Therapy for Severe Fall Exacerbations (ICAC-20)
Status: Enrolling
Updated: 1/22/2016
Boston University School of Medicine
mi
from
Boston, MA
Click here to add this to my saved trials
Preventative Omalizumab or Step-up Therapy for Severe Fall Exacerbations
Preventative Omalizumab or Step-up Therapy for Severe Fall Exacerbations (ICAC-20)
Status: Enrolling
Updated:  1/22/2016
Columbia University Medical Center
mi
from
New York, NY
Preventative Omalizumab or Step-up Therapy for Severe Fall Exacerbations
Preventative Omalizumab or Step-up Therapy for Severe Fall Exacerbations (ICAC-20)
Status: Enrolling
Updated: 1/22/2016
Columbia University Medical Center
mi
from
New York, NY
Click here to add this to my saved trials
Preventative Omalizumab or Step-up Therapy for Severe Fall Exacerbations
Preventative Omalizumab or Step-up Therapy for Severe Fall Exacerbations (ICAC-20)
Status: Enrolling
Updated:  1/22/2016
University of Texas Southwestern Medical Center
mi
from
Dallas, TX
Preventative Omalizumab or Step-up Therapy for Severe Fall Exacerbations
Preventative Omalizumab or Step-up Therapy for Severe Fall Exacerbations (ICAC-20)
Status: Enrolling
Updated: 1/22/2016
University of Texas Southwestern Medical Center
mi
from
Dallas, TX
Click here to add this to my saved trials
Preventative Omalizumab or Step-up Therapy for Severe Fall Exacerbations
Preventative Omalizumab or Step-up Therapy for Severe Fall Exacerbations (ICAC-20)
Status: Enrolling
Updated:  1/22/2016
Henry Ford Health System
mi
from
Detroit, MI
Preventative Omalizumab or Step-up Therapy for Severe Fall Exacerbations
Preventative Omalizumab or Step-up Therapy for Severe Fall Exacerbations (ICAC-20)
Status: Enrolling
Updated: 1/22/2016
Henry Ford Health System
mi
from
Detroit, MI
Click here to add this to my saved trials
Preventative Omalizumab or Step-up Therapy for Severe Fall Exacerbations
Preventative Omalizumab or Step-up Therapy for Severe Fall Exacerbations (ICAC-20)
Status: Enrolling
Updated:  1/22/2016
Cincinnati Children's Hospital
mi
from
Cincinnati, OH
Preventative Omalizumab or Step-up Therapy for Severe Fall Exacerbations
Preventative Omalizumab or Step-up Therapy for Severe Fall Exacerbations (ICAC-20)
Status: Enrolling
Updated: 1/22/2016
Cincinnati Children's Hospital
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Stimulation of the Cervical Sympathetic Ganglion for Treatment of Asthma
Stimulation of the Cervical Sympathetic Ganglion for Treatment of Asthma.
Status: Enrolling
Updated:  1/25/2016
Ohio State University
mi
from
Columbus, OH
Stimulation of the Cervical Sympathetic Ganglion for Treatment of Asthma
Stimulation of the Cervical Sympathetic Ganglion for Treatment of Asthma.
Status: Enrolling
Updated: 1/25/2016
Ohio State University
mi
from
Columbus, OH
Click here to add this to my saved trials
Mepolizumab Steroid-Sparing Study in Subjects With Severe Refractory Asthma
MEA115575: A Randomised, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Study of Mepolizumab Adjunctive Therapy to Reduce Steroid Use in Subjects With Severe Refractory Asthma
Status: Enrolling
Updated:  1/28/2016
GSK Investigational Site
mi
from
New Haven, CT
Mepolizumab Steroid-Sparing Study in Subjects With Severe Refractory Asthma
MEA115575: A Randomised, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Study of Mepolizumab Adjunctive Therapy to Reduce Steroid Use in Subjects With Severe Refractory Asthma
Status: Enrolling
Updated: 1/28/2016
GSK Investigational Site
mi
from
New Haven, CT
Click here to add this to my saved trials
Mepolizumab Steroid-Sparing Study in Subjects With Severe Refractory Asthma
MEA115575: A Randomised, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Study of Mepolizumab Adjunctive Therapy to Reduce Steroid Use in Subjects With Severe Refractory Asthma
Status: Enrolling
Updated:  1/28/2016
GSK Investigational Site
mi
from
Rochester, MN
Mepolizumab Steroid-Sparing Study in Subjects With Severe Refractory Asthma
MEA115575: A Randomised, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Study of Mepolizumab Adjunctive Therapy to Reduce Steroid Use in Subjects With Severe Refractory Asthma
Status: Enrolling
Updated: 1/28/2016
GSK Investigational Site
mi
from
Rochester, MN
Click here to add this to my saved trials
Mepolizumab Steroid-Sparing Study in Subjects With Severe Refractory Asthma
MEA115575: A Randomised, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Study of Mepolizumab Adjunctive Therapy to Reduce Steroid Use in Subjects With Severe Refractory Asthma
Status: Enrolling
Updated:  1/28/2016
GSK Investigational Site
mi
from
Cincinnati, OH
Mepolizumab Steroid-Sparing Study in Subjects With Severe Refractory Asthma
MEA115575: A Randomised, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Study of Mepolizumab Adjunctive Therapy to Reduce Steroid Use in Subjects With Severe Refractory Asthma
Status: Enrolling
Updated: 1/28/2016
GSK Investigational Site
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Mepolizumab Steroid-Sparing Study in Subjects With Severe Refractory Asthma
MEA115575: A Randomised, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Study of Mepolizumab Adjunctive Therapy to Reduce Steroid Use in Subjects With Severe Refractory Asthma
Status: Enrolling
Updated:  1/28/2016
GSK Investigational Site
mi
from
Long Beach, CA
Mepolizumab Steroid-Sparing Study in Subjects With Severe Refractory Asthma
MEA115575: A Randomised, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Study of Mepolizumab Adjunctive Therapy to Reduce Steroid Use in Subjects With Severe Refractory Asthma
Status: Enrolling
Updated: 1/28/2016
GSK Investigational Site
mi
from
Long Beach, CA
Click here to add this to my saved trials
Mepolizumab Steroid-Sparing Study in Subjects With Severe Refractory Asthma
MEA115575: A Randomised, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Study of Mepolizumab Adjunctive Therapy to Reduce Steroid Use in Subjects With Severe Refractory Asthma
Status: Enrolling
Updated:  1/28/2016
GSK Investigational Site
mi
from
Denver, CO
Mepolizumab Steroid-Sparing Study in Subjects With Severe Refractory Asthma
MEA115575: A Randomised, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Study of Mepolizumab Adjunctive Therapy to Reduce Steroid Use in Subjects With Severe Refractory Asthma
Status: Enrolling
Updated: 1/28/2016
GSK Investigational Site
mi
from
Denver, CO
Click here to add this to my saved trials
Mepolizumab Steroid-Sparing Study in Subjects With Severe Refractory Asthma
MEA115575: A Randomised, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Study of Mepolizumab Adjunctive Therapy to Reduce Steroid Use in Subjects With Severe Refractory Asthma
Status: Enrolling
Updated:  1/28/2016
GSK Investigational Site
mi
from
St. Louis, MO
Mepolizumab Steroid-Sparing Study in Subjects With Severe Refractory Asthma
MEA115575: A Randomised, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Study of Mepolizumab Adjunctive Therapy to Reduce Steroid Use in Subjects With Severe Refractory Asthma
Status: Enrolling
Updated: 1/28/2016
GSK Investigational Site
mi
from
St. Louis, MO
Click here to add this to my saved trials
Mepolizumab Steroid-Sparing Study in Subjects With Severe Refractory Asthma
MEA115575: A Randomised, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Study of Mepolizumab Adjunctive Therapy to Reduce Steroid Use in Subjects With Severe Refractory Asthma
Status: Enrolling
Updated:  1/28/2016
GSK Investigational Site
mi
from
Pittsburg, PA
Mepolizumab Steroid-Sparing Study in Subjects With Severe Refractory Asthma
MEA115575: A Randomised, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Study of Mepolizumab Adjunctive Therapy to Reduce Steroid Use in Subjects With Severe Refractory Asthma
Status: Enrolling
Updated: 1/28/2016
GSK Investigational Site
mi
from
Pittsburg, PA
Click here to add this to my saved trials
Mepolizumab Steroid-Sparing Study in Subjects With Severe Refractory Asthma
MEA115575: A Randomised, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Study of Mepolizumab Adjunctive Therapy to Reduce Steroid Use in Subjects With Severe Refractory Asthma
Status: Enrolling
Updated:  1/28/2016
GSK Investigational Site
mi
from
Spartanburg, SC
Mepolizumab Steroid-Sparing Study in Subjects With Severe Refractory Asthma
MEA115575: A Randomised, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Study of Mepolizumab Adjunctive Therapy to Reduce Steroid Use in Subjects With Severe Refractory Asthma
Status: Enrolling
Updated: 1/28/2016
GSK Investigational Site
mi
from
Spartanburg, SC
Click here to add this to my saved trials
Mepolizumab Steroid-Sparing Study in Subjects With Severe Refractory Asthma
MEA115575: A Randomised, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Study of Mepolizumab Adjunctive Therapy to Reduce Steroid Use in Subjects With Severe Refractory Asthma
Status: Enrolling
Updated:  1/28/2016
GSK Investigational Site
mi
from
New Lambton,
Mepolizumab Steroid-Sparing Study in Subjects With Severe Refractory Asthma
MEA115575: A Randomised, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Study of Mepolizumab Adjunctive Therapy to Reduce Steroid Use in Subjects With Severe Refractory Asthma
Status: Enrolling
Updated: 1/28/2016
GSK Investigational Site
mi
from
New Lambton,
Click here to add this to my saved trials
Study of T-Regulatory Cells in Asthma
Study of T-Regulatory Cells in Asthma
Status: Enrolling
Updated:  1/28/2016
North Shore - LIJ Health System
mi
from
New Hyde Park, NY
Study of T-Regulatory Cells in Asthma
Study of T-Regulatory Cells in Asthma
Status: Enrolling
Updated: 1/28/2016
North Shore - LIJ Health System
mi
from
New Hyde Park, NY
Click here to add this to my saved trials
Comparing Types of Implementation of a Shared Decision Making Intervention
Comparing Traditional and Participatory Dissemination of a Shared Decision Making Intervention
Status: Enrolling
Updated:  2/1/2016
Department of Family Medicine
mi
from
Charlotte, NC
Comparing Types of Implementation of a Shared Decision Making Intervention
Comparing Traditional and Participatory Dissemination of a Shared Decision Making Intervention
Status: Enrolling
Updated: 2/1/2016
Department of Family Medicine
mi
from
Charlotte, NC
Click here to add this to my saved trials
Stress, Environment, and Genetics in Urban Children With Asthma
Stress, Environment, and Genetics in Urban Asthma
Status: Enrolling
Updated:  2/2/2016
Brigham and Women's Hosp
mi
from
Boston, MA
Stress, Environment, and Genetics in Urban Children With Asthma
Stress, Environment, and Genetics in Urban Asthma
Status: Enrolling
Updated: 2/2/2016
Brigham and Women's Hosp
mi
from
Boston, MA
Click here to add this to my saved trials
Mobile CHESS Research on Emergency Medical Services for Children
Mobile CHESS Research on Emergency Medical Services for Children
Status: Enrolling
Updated:  2/3/2016
Managed Health Services
mi
from
Milwaukee, WI
Mobile CHESS Research on Emergency Medical Services for Children
Mobile CHESS Research on Emergency Medical Services for Children
Status: Enrolling
Updated: 2/3/2016
Managed Health Services
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Mobile CHESS Research on Emergency Medical Services for Children
Mobile CHESS Research on Emergency Medical Services for Children
Status: Enrolling
Updated:  2/3/2016
United Healthcare
mi
from
Milwaukee, WI
Mobile CHESS Research on Emergency Medical Services for Children
Mobile CHESS Research on Emergency Medical Services for Children
Status: Enrolling
Updated: 2/3/2016
United Healthcare
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Efficacy and Safety Comparison of Albuterol Spiromax® and ProAir® Hydrofluoroalkane (HFA) in Pediatric Patients
A Single-Dose, Multicenter, Randomized, Double-Blind, Double-Dummy, Placebo-Controlled, Five-Period Crossover, Dose-Ranging Efficacy and Safety Comparison of Albuterol Spiromax® and ProAir® HFA in Pediatric Patients With Persistent Asthma
Status: Enrolling
Updated:  2/5/2016
Teva Investigational Site
mi
from
Birmingham, AL
Efficacy and Safety Comparison of Albuterol Spiromax® and ProAir® Hydrofluoroalkane (HFA) in Pediatric Patients
A Single-Dose, Multicenter, Randomized, Double-Blind, Double-Dummy, Placebo-Controlled, Five-Period Crossover, Dose-Ranging Efficacy and Safety Comparison of Albuterol Spiromax® and ProAir® HFA in Pediatric Patients With Persistent Asthma
Status: Enrolling
Updated: 2/5/2016
Teva Investigational Site
mi
from
Birmingham, AL
Click here to add this to my saved trials
Efficacy and Safety Comparison of Albuterol Spiromax® and ProAir® Hydrofluoroalkane (HFA) in Pediatric Patients
A Single-Dose, Multicenter, Randomized, Double-Blind, Double-Dummy, Placebo-Controlled, Five-Period Crossover, Dose-Ranging Efficacy and Safety Comparison of Albuterol Spiromax® and ProAir® HFA in Pediatric Patients With Persistent Asthma
Status: Enrolling
Updated:  2/5/2016
Teva Investigational Site 024
mi
from
Little Rock, AK
Efficacy and Safety Comparison of Albuterol Spiromax® and ProAir® Hydrofluoroalkane (HFA) in Pediatric Patients
A Single-Dose, Multicenter, Randomized, Double-Blind, Double-Dummy, Placebo-Controlled, Five-Period Crossover, Dose-Ranging Efficacy and Safety Comparison of Albuterol Spiromax® and ProAir® HFA in Pediatric Patients With Persistent Asthma
Status: Enrolling
Updated: 2/5/2016
Teva Investigational Site 024
mi
from
Little Rock, AK
Click here to add this to my saved trials
Efficacy and Safety Comparison of Albuterol Spiromax® and ProAir® Hydrofluoroalkane (HFA) in Pediatric Patients
A Single-Dose, Multicenter, Randomized, Double-Blind, Double-Dummy, Placebo-Controlled, Five-Period Crossover, Dose-Ranging Efficacy and Safety Comparison of Albuterol Spiromax® and ProAir® HFA in Pediatric Patients With Persistent Asthma
Status: Enrolling
Updated:  2/5/2016
Teva Investigational Site 10163
mi
from
Costa Mesa, CA
Efficacy and Safety Comparison of Albuterol Spiromax® and ProAir® Hydrofluoroalkane (HFA) in Pediatric Patients
A Single-Dose, Multicenter, Randomized, Double-Blind, Double-Dummy, Placebo-Controlled, Five-Period Crossover, Dose-Ranging Efficacy and Safety Comparison of Albuterol Spiromax® and ProAir® HFA in Pediatric Patients With Persistent Asthma
Status: Enrolling
Updated: 2/5/2016
Teva Investigational Site 10163
mi
from
Costa Mesa, CA
Click here to add this to my saved trials
Efficacy and Safety Comparison of Albuterol Spiromax® and ProAir® Hydrofluoroalkane (HFA) in Pediatric Patients
A Single-Dose, Multicenter, Randomized, Double-Blind, Double-Dummy, Placebo-Controlled, Five-Period Crossover, Dose-Ranging Efficacy and Safety Comparison of Albuterol Spiromax® and ProAir® HFA in Pediatric Patients With Persistent Asthma
Status: Enrolling
Updated:  2/5/2016
Teva Investigational Site 10140
mi
from
Orange, CA
Efficacy and Safety Comparison of Albuterol Spiromax® and ProAir® Hydrofluoroalkane (HFA) in Pediatric Patients
A Single-Dose, Multicenter, Randomized, Double-Blind, Double-Dummy, Placebo-Controlled, Five-Period Crossover, Dose-Ranging Efficacy and Safety Comparison of Albuterol Spiromax® and ProAir® HFA in Pediatric Patients With Persistent Asthma
Status: Enrolling
Updated: 2/5/2016
Teva Investigational Site 10140
mi
from
Orange, CA
Click here to add this to my saved trials
Efficacy and Safety Comparison of Albuterol Spiromax® and ProAir® Hydrofluoroalkane (HFA) in Pediatric Patients
A Single-Dose, Multicenter, Randomized, Double-Blind, Double-Dummy, Placebo-Controlled, Five-Period Crossover, Dose-Ranging Efficacy and Safety Comparison of Albuterol Spiromax® and ProAir® HFA in Pediatric Patients With Persistent Asthma
Status: Enrolling
Updated:  2/5/2016
Teva Investigational Site 10179
mi
from
San Jose, CA
Efficacy and Safety Comparison of Albuterol Spiromax® and ProAir® Hydrofluoroalkane (HFA) in Pediatric Patients
A Single-Dose, Multicenter, Randomized, Double-Blind, Double-Dummy, Placebo-Controlled, Five-Period Crossover, Dose-Ranging Efficacy and Safety Comparison of Albuterol Spiromax® and ProAir® HFA in Pediatric Patients With Persistent Asthma
Status: Enrolling
Updated: 2/5/2016
Teva Investigational Site 10179
mi
from
San Jose, CA
Click here to add this to my saved trials
Efficacy and Safety Comparison of Albuterol Spiromax® and ProAir® Hydrofluoroalkane (HFA) in Pediatric Patients
A Single-Dose, Multicenter, Randomized, Double-Blind, Double-Dummy, Placebo-Controlled, Five-Period Crossover, Dose-Ranging Efficacy and Safety Comparison of Albuterol Spiromax® and ProAir® HFA in Pediatric Patients With Persistent Asthma
Status: Enrolling
Updated:  2/5/2016
Teva Investigational Site 10168
mi
from
Lawrenceville, GA
Efficacy and Safety Comparison of Albuterol Spiromax® and ProAir® Hydrofluoroalkane (HFA) in Pediatric Patients
A Single-Dose, Multicenter, Randomized, Double-Blind, Double-Dummy, Placebo-Controlled, Five-Period Crossover, Dose-Ranging Efficacy and Safety Comparison of Albuterol Spiromax® and ProAir® HFA in Pediatric Patients With Persistent Asthma
Status: Enrolling
Updated: 2/5/2016
Teva Investigational Site 10168
mi
from
Lawrenceville, GA
Click here to add this to my saved trials
Efficacy and Safety Comparison of Albuterol Spiromax® and ProAir® Hydrofluoroalkane (HFA) in Pediatric Patients
A Single-Dose, Multicenter, Randomized, Double-Blind, Double-Dummy, Placebo-Controlled, Five-Period Crossover, Dose-Ranging Efficacy and Safety Comparison of Albuterol Spiromax® and ProAir® HFA in Pediatric Patients With Persistent Asthma
Status: Enrolling
Updated:  2/5/2016
Teva Investigational Site
mi
from
Savannah, GA
Efficacy and Safety Comparison of Albuterol Spiromax® and ProAir® Hydrofluoroalkane (HFA) in Pediatric Patients
A Single-Dose, Multicenter, Randomized, Double-Blind, Double-Dummy, Placebo-Controlled, Five-Period Crossover, Dose-Ranging Efficacy and Safety Comparison of Albuterol Spiromax® and ProAir® HFA in Pediatric Patients With Persistent Asthma
Status: Enrolling
Updated: 2/5/2016
Teva Investigational Site
mi
from
Savannah, GA
Click here to add this to my saved trials
Efficacy and Safety Comparison of Albuterol Spiromax® and ProAir® Hydrofluoroalkane (HFA) in Pediatric Patients
A Single-Dose, Multicenter, Randomized, Double-Blind, Double-Dummy, Placebo-Controlled, Five-Period Crossover, Dose-Ranging Efficacy and Safety Comparison of Albuterol Spiromax® and ProAir® HFA in Pediatric Patients With Persistent Asthma
Status: Enrolling
Updated:  2/5/2016
Teva Investigational Site 10493
mi
from
Normal, IL
Efficacy and Safety Comparison of Albuterol Spiromax® and ProAir® Hydrofluoroalkane (HFA) in Pediatric Patients
A Single-Dose, Multicenter, Randomized, Double-Blind, Double-Dummy, Placebo-Controlled, Five-Period Crossover, Dose-Ranging Efficacy and Safety Comparison of Albuterol Spiromax® and ProAir® HFA in Pediatric Patients With Persistent Asthma
Status: Enrolling
Updated: 2/5/2016
Teva Investigational Site 10493
mi
from
Normal, IL
Click here to add this to my saved trials
Efficacy and Safety Comparison of Albuterol Spiromax® and ProAir® Hydrofluoroalkane (HFA) in Pediatric Patients
A Single-Dose, Multicenter, Randomized, Double-Blind, Double-Dummy, Placebo-Controlled, Five-Period Crossover, Dose-Ranging Efficacy and Safety Comparison of Albuterol Spiromax® and ProAir® HFA in Pediatric Patients With Persistent Asthma
Status: Enrolling
Updated:  2/5/2016
Teva Investigational Site 59
mi
from
Missoula, MT
Efficacy and Safety Comparison of Albuterol Spiromax® and ProAir® Hydrofluoroalkane (HFA) in Pediatric Patients
A Single-Dose, Multicenter, Randomized, Double-Blind, Double-Dummy, Placebo-Controlled, Five-Period Crossover, Dose-Ranging Efficacy and Safety Comparison of Albuterol Spiromax® and ProAir® HFA in Pediatric Patients With Persistent Asthma
Status: Enrolling
Updated: 2/5/2016
Teva Investigational Site 59
mi
from
Missoula, MT
Click here to add this to my saved trials
Efficacy and Safety Comparison of Albuterol Spiromax® and ProAir® Hydrofluoroalkane (HFA) in Pediatric Patients
A Single-Dose, Multicenter, Randomized, Double-Blind, Double-Dummy, Placebo-Controlled, Five-Period Crossover, Dose-Ranging Efficacy and Safety Comparison of Albuterol Spiromax® and ProAir® HFA in Pediatric Patients With Persistent Asthma
Status: Enrolling
Updated:  2/5/2016
Teva Investigational Site
mi
from
Raleigh, NC
Efficacy and Safety Comparison of Albuterol Spiromax® and ProAir® Hydrofluoroalkane (HFA) in Pediatric Patients
A Single-Dose, Multicenter, Randomized, Double-Blind, Double-Dummy, Placebo-Controlled, Five-Period Crossover, Dose-Ranging Efficacy and Safety Comparison of Albuterol Spiromax® and ProAir® HFA in Pediatric Patients With Persistent Asthma
Status: Enrolling
Updated: 2/5/2016
Teva Investigational Site
mi
from
Raleigh, NC
Click here to add this to my saved trials
Efficacy and Safety Comparison of Albuterol Spiromax® and ProAir® Hydrofluoroalkane (HFA) in Pediatric Patients
A Single-Dose, Multicenter, Randomized, Double-Blind, Double-Dummy, Placebo-Controlled, Five-Period Crossover, Dose-Ranging Efficacy and Safety Comparison of Albuterol Spiromax® and ProAir® HFA in Pediatric Patients With Persistent Asthma
Status: Enrolling
Updated:  2/5/2016
Teva Investigational Site
mi
from
Oklahoma City, OK
Efficacy and Safety Comparison of Albuterol Spiromax® and ProAir® Hydrofluoroalkane (HFA) in Pediatric Patients
A Single-Dose, Multicenter, Randomized, Double-Blind, Double-Dummy, Placebo-Controlled, Five-Period Crossover, Dose-Ranging Efficacy and Safety Comparison of Albuterol Spiromax® and ProAir® HFA in Pediatric Patients With Persistent Asthma
Status: Enrolling
Updated: 2/5/2016
Teva Investigational Site
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Efficacy and Safety Comparison of Albuterol Spiromax® and ProAir® Hydrofluoroalkane (HFA) in Pediatric Patients
A Single-Dose, Multicenter, Randomized, Double-Blind, Double-Dummy, Placebo-Controlled, Five-Period Crossover, Dose-Ranging Efficacy and Safety Comparison of Albuterol Spiromax® and ProAir® HFA in Pediatric Patients With Persistent Asthma
Status: Enrolling
Updated:  2/5/2016
Teva Investigational Site
mi
from
Portland, OR
Efficacy and Safety Comparison of Albuterol Spiromax® and ProAir® Hydrofluoroalkane (HFA) in Pediatric Patients
A Single-Dose, Multicenter, Randomized, Double-Blind, Double-Dummy, Placebo-Controlled, Five-Period Crossover, Dose-Ranging Efficacy and Safety Comparison of Albuterol Spiromax® and ProAir® HFA in Pediatric Patients With Persistent Asthma
Status: Enrolling
Updated: 2/5/2016
Teva Investigational Site
mi
from
Portland, OR
Click here to add this to my saved trials
Efficacy and Safety Comparison of Albuterol Spiromax® and ProAir® Hydrofluoroalkane (HFA) in Pediatric Patients
A Single-Dose, Multicenter, Randomized, Double-Blind, Double-Dummy, Placebo-Controlled, Five-Period Crossover, Dose-Ranging Efficacy and Safety Comparison of Albuterol Spiromax® and ProAir® HFA in Pediatric Patients With Persistent Asthma
Status: Enrolling
Updated:  2/5/2016
Teva Investigational Site 1366
mi
from
Charleston, SC
Efficacy and Safety Comparison of Albuterol Spiromax® and ProAir® Hydrofluoroalkane (HFA) in Pediatric Patients
A Single-Dose, Multicenter, Randomized, Double-Blind, Double-Dummy, Placebo-Controlled, Five-Period Crossover, Dose-Ranging Efficacy and Safety Comparison of Albuterol Spiromax® and ProAir® HFA in Pediatric Patients With Persistent Asthma
Status: Enrolling
Updated: 2/5/2016
Teva Investigational Site 1366
mi
from
Charleston, SC
Click here to add this to my saved trials
Efficacy and Safety Comparison of Albuterol Spiromax® and ProAir® Hydrofluoroalkane (HFA) in Pediatric Patients
A Single-Dose, Multicenter, Randomized, Double-Blind, Double-Dummy, Placebo-Controlled, Five-Period Crossover, Dose-Ranging Efficacy and Safety Comparison of Albuterol Spiromax® and ProAir® HFA in Pediatric Patients With Persistent Asthma
Status: Enrolling
Updated:  2/5/2016
Teva Investigational Site 10199
mi
from
Orangeburg, SC
Efficacy and Safety Comparison of Albuterol Spiromax® and ProAir® Hydrofluoroalkane (HFA) in Pediatric Patients
A Single-Dose, Multicenter, Randomized, Double-Blind, Double-Dummy, Placebo-Controlled, Five-Period Crossover, Dose-Ranging Efficacy and Safety Comparison of Albuterol Spiromax® and ProAir® HFA in Pediatric Patients With Persistent Asthma
Status: Enrolling
Updated: 2/5/2016
Teva Investigational Site 10199
mi
from
Orangeburg, SC
Click here to add this to my saved trials
Efficacy and Safety Comparison of Albuterol Spiromax® and ProAir® Hydrofluoroalkane (HFA) in Pediatric Patients
A Single-Dose, Multicenter, Randomized, Double-Blind, Double-Dummy, Placebo-Controlled, Five-Period Crossover, Dose-Ranging Efficacy and Safety Comparison of Albuterol Spiromax® and ProAir® HFA in Pediatric Patients With Persistent Asthma
Status: Enrolling
Updated:  2/5/2016
Teva Investigational Site 10517
mi
from
Spartanburg, SC
Efficacy and Safety Comparison of Albuterol Spiromax® and ProAir® Hydrofluoroalkane (HFA) in Pediatric Patients
A Single-Dose, Multicenter, Randomized, Double-Blind, Double-Dummy, Placebo-Controlled, Five-Period Crossover, Dose-Ranging Efficacy and Safety Comparison of Albuterol Spiromax® and ProAir® HFA in Pediatric Patients With Persistent Asthma
Status: Enrolling
Updated: 2/5/2016
Teva Investigational Site 10517
mi
from
Spartanburg, SC
Click here to add this to my saved trials
Efficacy and Safety Comparison of Albuterol Spiromax® and ProAir® Hydrofluoroalkane (HFA) in Pediatric Patients
A Single-Dose, Multicenter, Randomized, Double-Blind, Double-Dummy, Placebo-Controlled, Five-Period Crossover, Dose-Ranging Efficacy and Safety Comparison of Albuterol Spiromax® and ProAir® HFA in Pediatric Patients With Persistent Asthma
Status: Enrolling
Updated:  2/5/2016
Teva Investigational Site 10119
mi
from
Boerne, TX
Efficacy and Safety Comparison of Albuterol Spiromax® and ProAir® Hydrofluoroalkane (HFA) in Pediatric Patients
A Single-Dose, Multicenter, Randomized, Double-Blind, Double-Dummy, Placebo-Controlled, Five-Period Crossover, Dose-Ranging Efficacy and Safety Comparison of Albuterol Spiromax® and ProAir® HFA in Pediatric Patients With Persistent Asthma
Status: Enrolling
Updated: 2/5/2016
Teva Investigational Site 10119
mi
from
Boerne, TX
Click here to add this to my saved trials